Trially CEO Kyle McAllister explains why transparent AI reasoning is essential for trial patient matching.
Feature|Videos|February 13, 2025 (Updated: March 4, 2025)
Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Author(s)Lightship
Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research organization (CRO) partners to support clinical trials that are patient-first and accessible.
Lightship prioritizes patient accessibility and centricity in clinical trials, ensuring a seamless and positive experience for every participant. Learn more about:
- Lightship's mission and core purpose as a company
- How Lightship’s mobile nursing teams and home visits enhance study participation and retention
- The role of mobile research units in the community and how they enhance participant education, accessibility, and convenience
Related to this article
Trially Co-founder and CEO Kyle McAllister, explains how AI absorbing the bulk of clinical-trial chart reviews can free research sites to focus staff time on higher-value tasks.
Trending on Applied Clinical Trials Online
1
Real-Time Clinical Trials Depend on a Scalable EHR-to-EDC Connection
2
What It Actually Means to Embed AI Across the Clinical Operating Model
3
FDA Launches Rare Disease Framework Initiative to Reimagine Drug Development for Small Patient Populations
4
Real-World Oncology Data: From Treatment Patterns to Novel Therapies
5